Application no. and date | 12783804.3 (espacenet) (Federated) (European Patent Register), 20121031 | Patent/reg. no. and date | DK/EP 2780011, 20180411 | Publication date | 20140924 | Priority no. and date | US 201161558582 P, 20111111 | EP pub. no. and date |
EP 2780011 20140924 | Effective date | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | P81801331DK00E | Inventor | CHAN, Edward, Michael, Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, PRATT, Susan, Elizabeth, Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, STANCATO, Louis, Frank, Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/282 (2006.01) , A61K 31/437 (2006.01) , A61K 31/555 (2006.01) , A61K 31/7068 (2006.01) , A61K 33/24 (2006.01) , A61P 35/00 (2006.01) | Title | KOMBINATIONSTERAPI MOD OVARIECANCER | Int. application no. | US2012062634 | Int. publication no. | WO2013070460 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|